True Private Wealth Advisors Eli Lilly & CO Transaction History

True Private Wealth Advisors

$799 Million
Q3 2024

A detailed history of True Private Wealth Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, True Private Wealth Advisors holds 6,834 shares of LLY stock, worth $5.44 Million. This represents 0.76% of its overall portfolio holdings.

Number of Shares

6,834

Previous 8,358 18.23%

Holding current value

$5.44 Million

Previous $7.57 Million 19.99%

% of portfolio

0.76%

Previous 0.89%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$772.14 - $960.02 $1.18 Million - $1.46 Million	-1,524 Reduced 18.23%	6,834 $6.05 Million
Q2 2024 Jul 16, 2024	SELL	$724.87 - $909.04 $454,493 - $569,968	-627 Reduced 6.98%	8,358 $7.57 Million
Q1 2024 Apr 25, 2024	SELL	$592.2 - $792.28 $60,996 - $81,604	-103 Reduced 1.13%	8,985 $6.99 Million
Q4 2023 Jan 30, 2024	BUY	$525.19 - $619.13 $16,806 - $19,812	32 Added 0.35%	9,088 $5.3 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $244,301 - $336,806	-562 Reduced 5.84%	9,056 $4.86 Million
Q2 2023 Aug 11, 2023	SELL	$350.74 - $468.98 $491,036 - $656,572	-1,400 Reduced 12.71%	9,618 $4.51 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $251,920 - $295,869	-811 Reduced 6.86%	11,018 $3.78 Million
Q4 2022 Feb 14, 2023	SELL	$321.55 - $374.67 $25,402 - $29,598	-79 Reduced 0.66%	11,829 $4.33 Million
Q3 2022 Nov 04, 2022	BUY	$296.48 - $337.87 $45,954 - $52,369	155 Added 1.32%	11,908 $3.85 Million
Q2 2022 Jul 28, 2022	BUY	$278.73 - $327.27 $186,749 - $219,270	670 Added 6.05%	11,753 $3.81 Million
Q1 2022 May 09, 2022	BUY	$234.69 - $291.66 $3,755 - $4,666	16 Added 0.14%	11,083 $3.27 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $3,372 - $4,185	15 Added 0.14%	11,067 $3.06 Million
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $257,720 - $317,161	-1,163 Reduced 9.52%	11,052 $2.55 Million
Q2 2021 Aug 10, 2021	SELL	$180.55 - $233.54 $5,235 - $6,772	-29 Reduced 0.24%	12,215 $2.8 Million
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $205,892 - $266,538	-1,253 Reduced 9.28%	12,244 $2.29 Million
Q4 2020 Jan 11, 2021	SELL	$130.46 - $172.63 $10,958 - $14,500	-84 Reduced 0.62%	13,497 $2.28 Million
Q3 2020 Oct 09, 2020	BUY	$146.22 - $169.13 $6,287 - $7,272	43 Added 0.32%	13,581 $2.01 Million
Q2 2020 Jul 07, 2020	SELL	$136.42 - $164.18 $415,808 - $500,420	-3,048 Reduced 18.38%	13,538 $2.22 Million
Q1 2020 Apr 20, 2020	BUY	$119.05 - $147.35 $171,908 - $212,773	1,444 Added 9.54%	16,586 $2.3 Million
Q4 2019 Jan 27, 2020	SELL	$106.92 - $132.43 $213,840 - $264,860	-2,000 Reduced 11.67%	15,142 $1.99 Million
Q2 2019 Aug 01, 2019	SELL	$110.79 - $129.32 $1,772 - $2,069	-16 Reduced 0.09%	17,142 $1.9 Million
Q1 2019 Apr 25, 2019	SELL	$111.31 - $131.02 $25,044 - $29,479	-225 Reduced 1.29%	17,158 $2.23 Million
Q4 2018 Jan 14, 2019	SELL	$105.9 - $118.64 $1,059 - $1,186	-10 Reduced 0.06%	17,383 $2.01 Million
Q3 2018 Oct 18, 2018	BUY	$85.86 - $107.31 $4,121 - $5,150	48 Added 0.28%	17,393 $0
Q2 2018 Jul 13, 2018	SELL	$75.7 - $86.88 $16,881 - $19,374	-223 Reduced 1.27%	17,345 $1.48 Million
Q1 2018 Apr 25, 2018	SELL	$74.21 - $87.6 $427,449 - $504,575	-5,760 Reduced 24.69%	17,568 $1.36 Million
Q4 2017 Jan 19, 2018	SELL	$81.94 - $87.89 $32,284 - $34,628	-394 Reduced 1.66%	23,328 $1.97 Million
Q3 2017 Oct 27, 2017	BUY	$77.07 - $85.54 $664,035 - $737,012	8,616 Added 57.04%	23,722 $2.03 Million
Q2 2017 Aug 07, 2017	BUY	N/A	15,106	15,106 $1.24 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on True Private Wealth Advisors with notifications on news.

Account

True Private Wealth Advisors Eli Lilly & CO Transaction History